Biblio

Add Citation
Export 6 results:
Sort by: Author [ Title (Desc)] Type Year
Filters: Author is Gitler, Aaron D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su L, et al. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci USA. 2008;105(1):145-50.
G
Xiong Y, Coombes CE, Kilaru A, Li X, Gitler AD, Bowers WJ, et al. GTPase activity plays a key role in the pathobiology of LRRK2. PLoS Genet. 2010;6(4):e1000902.
Moore DJ, Dawson VL, Dawson TM, Gitler AD, Xiong Y, Bowers WJ, et al. GTPase Activity Plays a Key Role in the Pathobiology of LRRK2. PLoS Genetics. 2010;6.
E
Rappley I, Gitler AD, Selvy PE, LaVoie MJ, Levy BD, Brown AH, et al. Evidence that alpha-synuclein does not inhibit phospholipase D. Biochemistry. 2009;48(5):1077-83.
A
Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, et al. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet. 2009;41(3):308-15.
Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science. 2006;313(5785):324-8.